PLx Pharma Inc banner
P

PLx Pharma Inc
F:1D5A

Watchlist Manager
PLx Pharma Inc
F:1D5A
Watchlist
Price: 0.0005 EUR
Market Cap: €210k

Profitability Summary

PLx Pharma Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
PLx Pharma Inc

Margins Comparison
PLx Pharma Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
PLx Pharma Inc
F:1D5A
210k EUR
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.3B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
232.3B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
220.2B GBP
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
PLx Pharma Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
PLx Pharma Inc
F:1D5A
210k EUR
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
997.2B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.6B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.3B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
303.5B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
232.3B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
220.2B GBP
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.7B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.6B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
PLx Pharma Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate